New research has found that pregnant women were poorly supported when it came to managing their asthma.
The women believed that their medication would interfere with their pregnancy and stopped treatment.
The study found that stopping asthma treatment incurred dangers, but found little evidence that regular doses caused adverse effects during pregnancy.
Halting treatment is dangerous to the fetus as it could restrict oxygen flow and lead to poor development. The mothers interviewed in the study, felt that asthma management was a low priority and did not properly understand the risks.
This study highlights the need for better asthma management during pregnancy including education and awareness.
Read more at Monash University